Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05258721 · ClinicalTrials.gov registry record · Phase 2
Efficacy of ClōSYS® Sensitive Fluoride Toothpaste and ClōSYS® Sensitive Rinse Regimen on MGI, PI and BOP
A Phase 2 study, sponsored by Rowpar Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT05258721 is a Phase 2 study that has completed, run by Rowpar Pharmaceuticals. The registered enrollment target is 60 participants.
The verdict
NCT05258721, a Phase 2 study, has completed, sponsored by Rowpar Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
90-day, self-controlled, longitudinal, non-blinded clinical trial which will measure changes in clinical parameters in participants with gingivitis and Stage I or II periodontitis who apply ClōSYS® Sensitive Fluoride Toothpaste and ClōSYS® Sensitive Rinse.
Interventions
- DRUG ClōSYS® Sensitive Fluoride Toothpaste
- OTHER ClōSYS® Sensitive Rinse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-07-06 |
| Est. Completion | 2022-10-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05258721
The ClinicalTrials.gov registry entry for NCT05258721 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rowpar Pharmaceuticals, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ClōSYS® Sensitive Fluoride Toothpaste is the first listed.
NCT05258721 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05258721 about?
NCT05258721 is a clinical study titled "Efficacy of ClōSYS® Sensitive Fluoride Toothpaste and ClōSYS® Sensitive Rinse Regimen on MGI, PI and BOP". 90-day, self-controlled, longitudinal, non-blinded clinical trial which will measure changes in clinical parameters in participants with gingivitis and Stage I or II periodontitis who apply ClōSYS® Sensitive Fluoride Toothpaste and ClōSYS® Sensitive Rinse.
What is the current status of trial NCT05258721?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2021-07-06. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT05258721?
The interventions under investigation include: ClōSYS® Sensitive Fluoride Toothpaste (DRUG), ClōSYS® Sensitive Rinse (OTHER).
Who is sponsoring clinical trial NCT05258721?
This trial is sponsored by Rowpar Pharmaceuticals, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.